Norway Investigates Two More Deaths Linked To Astra-Zeneca Vaccine
Published:
Medical specialists in Norway are investigating two more deaths after being vaccinated with AstraZeneca against the Wuhan coronavirus, European media reported.
Four cases were identified in the country in which the death of people could be provoked by the vaccine.
According to media reports, the two most recent deaths in Norway have a similar clinical picture after being vaccinated: blood clots and bleeding similar to those seen in people in other countries after being vaccinated with AstraZeneca. At the same time, such symptoms were not observed in people who received other vaccines against the Wuhan virus, in particular from Pfizer and BioNTech and Moderna.
Two more patients with similar symptoms after vaccination are currently being monitored at the Oslo University Hospital.
According to the company AstraZeneca, to date 17 million people have been vaccinated with its anti-Wuhan virus vaccine in the EU and the UK. At the same time, as of last week, about 40 cases of blood clots are known.
The World Health Organization last week recommended that countries continue to use the AstraZeneca coronavirus vaccine.
The Expert Committee on the Safety of Medicines of the European Medicines Agency, during the assessment of information on complications in those vaccinated with the AstraZeneca vaccine against coronavirus, assessed it as a safe and effective vaccine.